RUSSIA LAUNCHES MASSIVE DRONE AND MISSILE BARRAGE ON UKRAINE, KILLING AT LEAST 18 CIVILIANS AND STRIKING KYIV AND MULTIPLE CITIES. (PHOTO).

Image
 Russia launches massive drone and missile barrage on Ukraine, killing at least 18 civilians and striking Kyiv and multiple cities  Russia carried out a large-scale overnight assault on Ukraine, launching hundreds of drones and dozens of missiles that killed at least 18 civilians and wounded more than 100 others across multiple cities, officials said Tuesday. The strikes hit Kyiv, Dnipro and other regions, with emergency crews working through destroyed residential buildings where some victims were trapped under rubble. In Dnipro, rescuers recovered the bodies of a 3-year-old child and a mother and her 8-year-old son, while officials reported 12 deaths in the city and six in Kyiv. The bombardment stretched from night into daylight, with explosions reported across wide areas of the country. Kyiv residents had been on alert for days after warnings of a major aerial attack, including advisories for foreign diplomats to leave the capital. Despite those warnings, most remained in pl...

ZIMBABWE ROLLS OUT NEW HIV PREVENTION DRUG LENACAPAVIR. (PHOTO)


 Zimbabwe rolls out new HIV prevention drug lenacapavir


Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections.


Health Minister Douglas Mombeshora said the programme, funded by the U.S. and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.


"Today marks an important day in Zimbabwe's national response to HIV. We gather here to launch lenacapavir - a long-acting injectable option for HIV prevention - and to show our commitment to protecting life and ending AIDS as a public health threat," Mombeshora said, Reuters reported.


He said Zimbabwe received its first batch and injected some early adopters earlier this month, adding that the rollout would be done in phases.


Significant progress


Lenacapavir, developed by Gilead Sciences, is administered as a subcutaneous injection twice a year. Officials say it could help overcome adherence challenges associated with daily oral pre-exposure prophylaxis (PrEP) pills.


Zimbabwe has made significant progress in tackling HIV, achieving the 95-95-95 treatment targets set by U.N. programme UNAIDS — meaning 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those on treatment have suppressed viral loads.


Melody Dengu, a community leader in the Harare suburb of Epworth, said she had already received the jab earlier this month.


"I have also (so far) gotten 12 other people to come and get injected," she told Reuters at the event.


Zimbabwe has one of Africa's highest HIV burdens, though new infections have declined significantly over the past decade due to expanded testing, treatment and prevention.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).